Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

Press releases published on July 7, 2026

Jul. 7, 2026

AdCare Rhode Island Opens New Program to Support Recovery and Accountability Following Impaired Driving Offenses

Indeterminate GlobeNewswire

Jul. 7, 2026

Resmed Announces Agreement to Sell MatrixCare Business

Indeterminate GlobeNewswire

Jul. 7, 2026

ARS Pharmaceuticals Announces CEO Succession

Indeterminate GlobeNewswire

Jul. 7, 2026

Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation

Indeterminate GlobeNewswire

Jul. 7, 2026

Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing

Indeterminate GlobeNewswire

Jul. 7, 2026

Nyxoah Announces Preliminary Results for the Second Quarter of 2026

Indeterminate GlobeNewswire

Jul. 7, 2026

Vor Bio Appoints David Zaccardelli to Board of Directors

Indeterminate GlobeNewswire

Jul. 7, 2026

Memocept Supplement Facts Analysis: Latest Consumer Safety Report Issued Regarding Ingredients' Effectiveness & Side Effects Risk

Indeterminate GlobeNewswire

Jul. 7, 2026

PDFNJ Prescription Monitoring Webinar Set for July 9

Indeterminate GlobeNewswire

Jul. 7, 2026

Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy

Indeterminate GlobeNewswire

Jul. 7, 2026

Garbanzo Mediterranean Fresh Debuts New Loaded Fries Featuring Double Portions of Protein

Indeterminate GlobeNewswire

Jul. 7, 2026

Erdem Hospital Launches UK Patient Community with First London Wellness Event

Indeterminate GlobeNewswire

Jul. 7, 2026

Orthopedic Devices Market to Grow from USD 51.61 Billion in 2024 to USD 68.51 Billion by 2030, at a CAGR of 4.8% - MarketsandMarkets™

Indeterminate GlobeNewswire

Jul. 7, 2026

Luxe Treatment Center marks five years of addiction treatment in Las Vegas, surpassing 1,000 patients served

Indeterminate GlobeNewswire

Jul. 7, 2026

Chronic Kidney Disease Market to Reach $131.4 Billion by 2030, Driven by Rising Prevalence and Healthcare Infrastructure Investment

Indeterminate GlobeNewswire

Jul. 7, 2026

Oncotelic Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway

Indeterminate GlobeNewswire

Jul. 7, 2026

MAPS Publishes Ibogaine Investigator's Brochure as a Free, Open-Access Resource

Indeterminate GlobeNewswire

Jul. 7, 2026

Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases

Indeterminate GlobeNewswire

Jul. 7, 2026

European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process

Indeterminate GlobeNewswire

Jul. 7, 2026

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research

Indeterminate GlobeNewswire